LynxDx
PrivateLast Round
Grant
Sep 1, 2020
Total Funding Raised
$3.95M
Company Overview
LynxDx operates in Healthcare & Life Sciences and is based in Ann Arbor, Michigan. Its latest recorded funding round was a Grant round in September 2020.
LynxDx is a biotechnology company that develops innovative diagnostic solutions, including the MyProstateScore (MPS) urine test for prostate cancer risk assessment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LynxDx Comparables
Compare LynxDx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MiRNA Scientific | 86% | |
| NucleoBio Corp | 83% | |
| MDxHealth | 80% |
For institutional investors. Book with your work email.
LynxDx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 1, 2020 | ||||
| Grant | Jun 15, 2020 | ||||
| Seed | Jan 1, 2020 | ||||
| Grant | Sep 23, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
LynxDx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Innovation Partnerships | Seed |
| ID Ventures | Seed |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2026
Monthly visitors increased 32% MoM.
- Mar 5, 2026
Monthly visitors increased 81% MoM, reaching 8.5K.
For institutional investors. Book with your work email.
LynxDx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about LynxDx's valuation, stock price, and market status.
Is LynxDx a public or private company?
LynxDx is a private company.
What is the current stock price of LynxDx?
LynxDx is a private company, so its shares have no public market price. Caplight tracks LynxDx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is LynxDx worth (valuation)?
Valuation information for LynxDx is not publicly available.
Can I buy LynxDx stock?
LynxDx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was LynxDx's last funding round?
LynxDx's most recent funding round was Grant on September 1, 2020.
Who are the main investors in LynxDx?
Key investors in LynxDx include National Cancer Institute, Innovation Partnerships, ID Ventures, National Institutes of Health (NIH).
Will LynxDx IPO soon?
No public IPO plans have been announced for LynxDx.
How can I track LynxDx secondary market activity?
Caplight tracks bids, offers, and trades in LynxDx's shares on secondary markets.